TSG-01

· Shanghai Hongyitang Biopharmaceutical Technology Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TSG-01, covering 2022-10-26 to 2022-10-26. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IIa Clinical Trial on TSG-01 in the Treatment of Chronic Heart Failure in Patients With Coronary Heart Disease. [Phase 2]

See pricing